Search Results
Keyword:FIRST
First Clinical Treatment Successfully Completed with China's Domestic Superconducting Cyclotron Proton Therapy System by CYC-Ion
On the morning of August 7, the domestically developed superconducting cyclotron proton therapy system, independently developed by Hefei CYC-Ion Medical Technology Equipment Co., Ltd., completed the first clinical trial treatment of a subject at Hefei Ion Medical Center. This marks a significant breakthrough as the first domestically produced superconducting cyclotron proton radiation therapy system in China. The subject in this case was a lung cancer patient. The superconducting proton therapy system used in the trial is equipped with the SC240 superconducting cyclotron independently developed by CYC-Ion, featuring an ultra-large irradiation field and 360° full-angle beam delivery capability. The entire treatment process relied on multi-modal fusion 4D image-guided precise positioning, enabling dynamic adaptation and precise treatment. The equipment operated smoothly with low noise, and the treatment control software ran...
2026-08-07
First Validation of Novel PRI Technology: Existing PET Tracers Can Image Tissue Microenvironment
August 6, 2026 - A joint research team from the Graduate School of Engineering at the University of Tokyo and the University of York in the UK announced that they have established a novel geometric imaging principle utilizing positron three-photon decay and successfully validated Positronium Ratio Imaging (PRI) technology for the first time. This method can be used in conjunction with existing clinical PET tracers and is expected to provide a new means of observing tissue microenvironments in nuclear medicine imaging. Conceptual diagram of next-generation nuclear medicine imaging utilizing positron-3-photon decay. Current clinical PET scans primarily rely on the positron two-photon annihilation process to visualize the distribution and accumulation of tracers in the body, but they provide limited information on microenvironmental factors such as tissue hypoxia that are associated with disease malignancy...
2026-08-07
First Observation of Anti-Kaonic Nuclei in Photon Beam Experiments
The LEPS2/Solenoid collaboration, composed of researchers from the Research Center for Nuclear Physics at Osaka University, Kyoto Sangyo University, the Research Center for Advanced Quantum Beam Science at Tohoku University, Korea University, Gifu University, the Institute of Modern Physics of the Chinese Academy of Sciences, RIKEN, Kyoto University, the Institute of Physics at Academia Sinica in Taiwan, and the University of Saskatchewan in Canada, has for the first time observed nuclei containing anti-kaons in a photon beam experiment. This achievement provides new experimental evidence confirming the existence of anti-kaonic nuclei and offers important clues for understanding high-density nuclear matter and the internal structure of neutron stars. The research team conducted the experiment at the LEPS2 laser-electron photon facility at the large synchrotron radiation facility SPring-8 in Hyogo Prefecture, Japan...
2026-08-07
Radioactivity test results for agricultural and fishery products in North Chungcheong Province, South Korea, pass standards in first half of the year
The Chungcheongbuk-do Institute of Health and Environment announced on August 7 that it conducted radioactivity safety testing on agricultural and fishery products sold and used within the province in the first half of this year, and the results showed that all relevant samples met food radioactivity safety standards. The testing covered 119 types of agricultural products and 274 types of fishery products sold at large supermarkets, local food direct-sale stores, or used as ingredients for school meals. Testing items included indicators such as radioactive iodine, radioactive cesium, and tritium. The test results showed that the levels of radioactive iodine and radioactive cesium in the samples did not exceed the permissible limit of 100 Bq/kg for food radioactivity; tritium was not detected in any of the 80 seafood samples. The relevant test results can be found on the Chungcheongbuk-do Institute of Health and Environment website.
2026-08-07
Rostec's RosEl Delivers First Batch of Vulkan Magnetic Contact Sensors
RosEl Holding Company (RosEl), a subsidiary of Rostec, has delivered the first batch of Vulkan magnetic contact sensors to customers. The product is designed for high-pressure steam pipeline applications and can be used in automation and signaling systems, including those at nuclear power plants. According to reports, Vulkan sensors are installed inside steam pipeline valves and are primarily used to monitor and control the valve closing process. The device can operate at temperatures up to 350 degrees Celsius, withstand mechanical shock acceleration of 150g, and achieve seismic category 1 rating, maintaining operational capability under strong earthquake conditions. The sensor features a stainless steel housing and has a design service life of up to 12 years. Its core reed switch...
2026-08-07
Rosatom Completes First Batch of Certification for Energy Critical Information Infrastructure Products
Rosatom has recently completed the first batch of product certification for critical information infrastructure in the fuel and energy sector under the KII-Sert voluntary certification system. The certification system has been operating in Russia's nuclear energy and aerospace industries since 2024, primarily used to assess the reliability, technological independence, and sustainability of solutions related to critical information infrastructure. The certification was carried out by Atomenergoproekt JSC, part of Rosatom's engineering division. As an authorized certification body for trusted products and processes within the KII-Sert system, the company, in cooperation with the industrial testing laboratory Avtomatika-Servis LLC, certified a software and hardware system used in the oil and gas industry.
2026-08-07
Oklo's Groves Isotope Test Reactor Achieves First Criticality
Oklo, a U.S. advanced nuclear technology company, announced on August 6 that its Groves Isotope Test Reactor has achieved a controlled self-sustaining nuclear chain reaction at low power, reaching first criticality. This milestone comes less than a year after the project broke ground. Groves Isotope Test Reactor facility (Image: Groves) The Groves low-power test reactor, located in Lockhart, Texas, is the first reactor to achieve criticality on private land under the U.S. Department of Energy's Reactor Pilot Program. According to Oklo, the facility was built from undeveloped land, completing civil excavation, engineering construction, component fabrication or procurement, fuel configuration, and...
2026-08-07
South Gyeongsang Province Completes 380 Food Radioactivity Tests in First Half of Year, All Meeting Standards
The Gyeongsangnam-do Institute of Health and Environment recently announced that in the first half of this year, it conducted radioactivity testing on agricultural products, aquatic products, and processed foods already in circulation, completing tests on 380 samples. Testing items included radioactive iodine, radioactive cesium, and tritium, with all results meeting food radiation-related standards. According to the institute, it continues to conduct radiation monitoring on foods with high market consumption to ensure the daily dietary safety of residents. Of the 380 tests completed in the first half of this year, 338 were for iodine and cesium, and 42 were for tritium, with no samples exceeding permissible levels. In terms of monitoring methods, the institute has established a...
2026-07-27
China's First Industry Standard for LOCA BEPU Analysis, Led by CGN Research Institute, Officially Released
Recently, approved by the National Energy Administration, the energy industry standard "Technical Requirements for Best Estimate Plus Uncertainty Analysis of Loss of Coolant Accident in Pressurized Water Reactor Nuclear Power Plants" (NB/T 20751-2026), led by CGN Research Institute, was officially released. The standard was developed under the leadership of the Research Institute, in collaboration with the Nuclear and Radiation Safety Center of the Ministry of Ecology and Environment, China Nuclear Power Research and Design Institute, Shanghai Nuclear Engineering Research and Design Institute, Hualong Nuclear Power Technology Co., Ltd., and China Nuclear Power Engineering Co., Ltd., among other organizations. It will come into effect on December 26, 2026. This standard is China's first BEPU analysis...
2026-08-06
South Korea Advances First Domestic Commercial Production of Lu-177 Using Wolsong Heavy Water Reactors
Korea Hydro & Nuclear Power (KHNP) plans to use the heavy water reactors at the Wolsong Nuclear Power Plant to produce, for the first time domestically, the radioisotope lutetium-177 (Lu-177) for cancer treatment. Currently, South Korea relies entirely on imports for this material, which imposes cost pressures and supply instability on local radiopharmaceutical companies such as Cellbion and FutureChem. Industry experts generally believe that domestic production will help build a diversified supply chain and shorten transportation times. The primary goal of this plan is to achieve commercial production of Lu-177, with pilot production expected in 2028 and full-scale production commencing in 2031. Subsequently, KHNP will expand production to include cobalt...
2026-08-06
Kazakhstan Welcomes Its First Cohort of Nuclear Industry Specialists
On August 5, the inaugural graduation ceremony was held in Almaty for the first cohort of students at the Kazakhstan branch campus of the National Research Nuclear University MEPhI (НИЯУ МИФИ). Timur Zhantikin, Vice Chairman of the Atomic Energy Agency of Kazakhstan, attended the ceremony and presented diplomas to the graduates. In his address, he noted that as Kazakhstan's atomic energy industry enters a new phase of development, the demand for specialized professionals continues to grow, and the targeted training programs offered by the branch campus are crucial to filling this gap. The graduation of this first cohort marks the beginning of Kazakhstan's establishment of an independent domestic nuclear talent cultivation system. For a long time, Kazakhstan's nuclear industry has relied on overseas education or on-the-job training to supplement its engineering workforce...
2026-08-06
"China Nuclear Power Development Report (2026)": China's Total Scale of Operating and Approved-Under-Construction Nuclear Power Units Ranks First in the World
On August 6, the National Energy Administration released the "China Nuclear Power Development Report (2026)". As of the end of 2025, China had a total of 112 nuclear power units in operation and approved for construction, with a total installed capacity of 125 million kilowatts, ranking first in the world. Among them, 59 units were in operation with an installed capacity of 62.48 million kilowatts, ranking third globally; 53 units were approved and under construction with a capacity of 62.93 million kilowatts, maintaining the world's largest nuclear power engineering construction scale for 19 consecutive years. The report shows that during the "14th Five-Year Plan" period, China newly approved 46 nuclear power units with a total capacity of 54.5 million kilowatts, and newly commissioned 11 units with a capacity of 12.45 million kilowatts. In 2025, China commissioned one new nuclear power unit, namely Unit 2 of the "Guohe One" demonstration project; and approved the construction of 10 new nuclear power units with a total capacity of 12.1 million kilowatts, involving Units 5 and 6 of Zhejiang Sanmen, Units 5 and 6 of Shandong Haiyang, Units 1 and 2 of Fujian Xiapu, Units 3 and 4 of Guangdong Taishan, and Units 5 and 6 of Guangxi Fangchenggang...
2026-08-06
BESIII Experiment First Confirms the Existence of Glueballs
On August 6, Beijing time, the international collaboration of the Beijing Spectrometer III experiment (BESIII) at the Beijing Electron-Positron Collider announced at the International Conference on High Energy Physics (ICHEP 2026) held in Brazil, in the form of a special plenary report: after 15 years of sustained research, the BESIII experiment has established a complete chain of evidence proving the existence of glueballs, unraveling the mystery that has puzzled the academic community for nearly half a century. This discovery not only provides a decisive validation of the theory of quantum chromodynamics, but also demonstrates the existence of a completely new form of matter—matter composed purely of force. Atomic nuclei are composed of protons and neutrons, which in turn are composed of quarks. Gluons mediate the strong interaction between quarks...
2026-08-06
Site Handover for Poland's First Commercial Nuclear Power Plant to Bechtel
New progress has been made in the construction of Poland's first commercial nuclear power plant. The Lubiatowo-Kopalino site in the Pomerania region of northern Poland has been handed over to Bechtel of the United States, and earthworks at the project site are underway. Polskie Elektrownie Jądrowe (PEJ), Poland's state-owned project company, stated that Bechtel has replaced PEJ as the site coordinator for the project. Under the Polish government's earlier arrangement, the nuclear power plant will feature three Westinghouse Electric Company AP1000 pressurized water reactor units. In 2023, Westinghouse Electric Company and Bechtel formed a consortium to jointly advance project implementation. The nuclear power plant is sited in the Lubiatowo-Kopalino area along the Baltic Sea coast in Poland.
2026-08-06
Thor Medical Commences Commercial Supply with First Delivery of High-Purity Thorium-228 from AlphaOne
Thor Medical ASA announced on August 5 that it has completed the first customer delivery of high-purity thorium-228 (Th-228) from its AlphaOne production facility at the Herøya industrial park. This marks the first customer shipment following the facility's production start announced last week, and signifies AlphaOne's entry into the commercial supply phase. Thor Medical CEO Jasper Kurth stated that commercial production represents the beginning of the company's industrial-scale manufacturing, and the first customer delivery demonstrates the company's transition from capacity building to serving customers through its first industrial-scale facility. The company stated that as production capacity gradually ramps up, it will continue to meet the growing demand for high-purity isotopes in the targeted alpha therapy field...
2026-08-06